ViewsML

Transforming Precision Medicine and Diagnostics with Virtual Biomarker Staining

Vancouver, United States · $4.9M raised

Headquarters
Vancouver
Employees
1–10
Business Model
B2B
Total Funding
$4.9M
Last Round
$4.9M SeedApr 2026
Rounds
1

About

ViewsML uses deep learning to convert routine pathology images into virtual biomarker staining results, eliminating time-consuming and tissue-destructive lab processes. Its platform provides per-cell spatial and quantitative biomarker insights from a single H&E slide, serving pharmaceutical companies, diagnostic labs, and healthcare systems pursuing faster, more scalable precision medicine.

Summary

ViewsML is an Artificial Intelligence company based in Vancouver, United States. It has raised $4.9M in total across 1 round, most recently a $4.9M Seed round in Apr 2026. Investors include Wittington Ventures and Mayo Clinic.

Tech & App Stack

8 technologies & apps tracked

Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

Investors

Similar Companies